CVS Health is outperforming Amazon in 2025, making it a better investment choice.

From Nasdaq: 2025-06-30 15:00:00

Amazon’s entry into healthcare, with acquisitions like PillPack and services like Amazon Pharmacy, has disrupted the industry. CVS Health, after a tough 2024, is making a strong comeback in 2025, boasting $95 billion in revenue and expanding its ecosystem. Investors are watching closely to see who will lead the future of healthcare delivery.

CVS leverages its physical footprint with over 9,000 retail locations, while Amazon focuses on logistics strength and tech-enabled services like at-home diagnostics in India. CVS offers integrated care locally, while Amazon emphasizes digital tools for efficiency and scalability. The rivalry is shaping up between physical access and digital deployment in healthcare.

CVS Health is the S&P 500’s eighth-best performer in 2025, with a 56% YTD return, outperforming Amazon at number 262 with a 1.8% gain. EPS projections show growth for both companies. CVS is attractively valued compared to Amazon, making it a buy, while Amazon remains a hold. CVS’s integrated strategy is yielding strong results in the market.

Zacks Investment Research highlights a top semiconductor stock with strong growth potential amidst rising demand for AI, ML, and IoT. Global semiconductor manufacturing is projected to reach $803 billion by 2028. For more stock recommendations and analysis, visit Zacks Investment Research. The battle between CVS and Amazon in healthcare continues, with CVS standing out as a better investment choice for its strong performance and focused strategy.



Read more at Nasdaq: CVS vs. Amazon: Healthcare Battle Continues- Which Stock to Buy Now?